Open AccessNonalcoholic fatty liver disease as a multi-systemic disease
Author(s) -
Hakan Fotbolcu,
Elçin Zorlu
Publication year - 2016
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v22.i16.4079
Subject(s) - nonalcoholic fatty liver disease , medicine , metabolic syndrome , fatty liver , insulin resistance , chronic liver disease , disease , gastroenterology , dyslipidemia , type 2 diabetes , kidney disease , liver disease , pathogenesis , steatohepatitis , steatosis , diabetes mellitus , population , obesity , cirrhosis , endocrinology , environmental health
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. NAFLD includes a wide spectrum of liver conditions ranging from simple steatosis to nonalcoholic steatohepatitis and advanced hepatic fibrosis. NAFLD has been recognized as a hepatic manifestation of metabolic syndrome linked with insulin resistance. NAFLD should be considered not only a liver specific disease but also an early mediator of systemic diseases. Therefore, NAFLD is usually associated with cardiovascular disease, chronic kidney disease, type 2 diabetes, obesity, and dyslipidemia. NAFLD is highly prevalent in the general population and is associated with increased cardiovascular morbidity and mortality. The underlying mechanisms and pathogenesis of NAFLD with regard to other medical disorders are not yet fully understood. This review focuses on pathogenesis of NAFLD and its relation with other systemic diseases.